Trials / Completed
CompletedNCT01952561
Expanded Use PK of Dapivirine Vaginal Ring
An Open-label, Parallel-group Pharmacokinetic Trial in Healthy HIV-negative Women to Characterize the Release Profile of Dapivirine Delivered by a Silicone Matrix Ring (Ring 004), Containing 25 mg of Dapivirine, Over Various Ring Use Periods
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- International Partnership for Microbicides, Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Study will evaluate the vaginal and blood pharmacokinetics of dapivirine from a vaginal ring containing 25 mg worn for 1, 2, 4, 8 or 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dapivirine ring |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2014-03-01
- Completion
- 2014-05-01
- First posted
- 2013-09-30
- Last updated
- 2016-08-26
Source: ClinicalTrials.gov record NCT01952561. Inclusion in this directory is not an endorsement.